Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Alimentary Pharmacology & Therapeutics|June 30, 2020
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosisChristian Labenz, Michael Nagel, Wolfgang M Kremer, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Deutsche Medizinische Wochenschrift (1946)|January 23, 2015
[Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome]Marc Nguyen-Tat, Esther Götz, Peter Scholz-Kreisel, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
European Journal of Internal Medicine|September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosisChristian Labenz, Michael Nagel, Gerrit Toenges, et al.
Hepatology Communications|October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosisSimon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Health Science Reports|June 17, 2021
Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goalChristoph Sarrazin, Christoph Boesecke, Solmaz Golsabahi-Broclawski, et al.
Pageof 9